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Abstract: In the present study, we aimed to
investigate the effects of dietary salt
restriction and loading on extracellular fluid
volume (ECFV), blood pressure (BP), heart
rate (HR), glomerular filtration rate (GFR)
and renal hypertrophy in diabetic rats.
Diabetes was induced by injection of
streptozotocin (STZ, 65 mg/kg, iv) into male
Wistar rats. Four groups were formed: a) the
diabetic rats given a standard rat diet (DC),
b) the diabetic rats given a high-salt diet
(DHS), c) the diabetic rats given a low-salt
diet (DLS), d) the nondiabetic rats given a
standard rat diet (C). Salt loading and salt
restriction were started 7 days after STZ
injection and continued for a one-week.
Diabetes did not affect ECFV and GFR values
significantly, but it led to renal hypertrophy, a
reduction in blood pressure (p<0.05) and a
reduction tendency in HR. Salt loading caused
a decrease in diastolic blood pressure (DBP)
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Introduction
Volume receptor reflex often is impaired in diabetes.
In previous studies, it has been concluded that STZtreated rats have impaired diuretic, natriuretic (1-3) and
plasma atrial natriuretic peptide (ANP) release (4)
responses to volume expansion. In addition, diabetes
often leads to renal hypertrophy and hyperfiltration but
their causes are not exactly clear (5-8). The adaptive
changes that may be due to increased fluid and electrolyte
turnover have been considered as possible reasons of
renal hypertrophy (6, 9-11). Thus, it seems that Na+ is a
key element in the process of renal hypertrophy, perhaps
causing the increases in glomerular filtration rate (GFR)
(9).
Generally, STZ-induced diabetic rats have volume
expansion (12). In diabetics, it has been accepted that the
attenuated natriuretic response to ANP and the enhanced
sodium retention during volume contraction could lead to
expanded extracellular fluid volume (ECFV) (13).

while salt restriction caused an increase in
DBP, but the differences were statistically
non-significant. However, these changes in
opposite directions caused a significant
difference between DLS and DHS. Both salt
loading and restriction increased ECFV
(p<0.05). GFR increased in DLS and tended
to increase in DHS. We determined a
significant correlation between ECFV and HR
only in C (r=0.72, p<0.05) and DHS (r=0.95, p<0.001) . We concluded that dietary
salt quantity can affect DBP and ECFV levels
and the alterations in ECFV may lead to
changes in GFR at diabetes. In addition, both
diabetes and dietary salt may modify the
feedback mechanisms that operate between
ECFV and HR.

Key Words: Diabetes, blood pressure,
extracellular fluid volume, glomerular
filtration rate, dietary salt.

In previous studies, low blood pressure (BP) and
bradycardia have often been recorded in diabetes, when
the measurements were made directly intra-arterially (9,
14). On the other hand, a high or normal BP level and
normal heart rate (HR) have been also reported in some
experiments (15-17). Differences among BP
measurements may be due to different salt intakes.
However, salt content of the diet is very rarely reported
in studies on diabetes. In addition, the abnormal fluid and
electrolyte handling that have effects on blood volume
may lead to the disturbances that are associated with
cardiovascular control in diabetes (9, 18).
We were unable to find any literature about the
effects of different salt diets on GFR, body fluid volumes
and cardiovascular parameters, together, in diabetic rats.
In the present study, because of high Na+ turnover we
evaluated the effects of low and high-salt diets on GFR,
renal hypertrophy, ECFV, BP and HR values in diabetes.
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GROUP

BW1

BW2

Glucose

ECFV

GFR

RW

(g)

(g)

(mmol/L)

(mL/kg)

(mL/min)

(mg)

(100 g BW)

C

307.11

320.11

10.88

331.20

0.51

695.78

±11.26

±32.68

±1.67

±24.01

±0.19

±65.49

(n=9)
DC

Table 1.

Body
weights,
plasma
glucose level, extracellular
fluid volume, glomerular
filtration rate and kidney
weight in experimental
groups.

(n=6)
314.86

252.57

39.71

353.15

0.42

898.00

±19.88

±19.58φ*

±6.61#

43.65

±0.14

±78.97#

305.13

238.13

38.51

415.04

0.85

913.50

±6.33

±17.74φ*

±6.44#

±45.64#**

±0.55

±91.02#

(n=6)
DHS

(n=8)
DLS

(n=6)
300.00

233.00

37.66

415.86

0.98

932.00

±8.70

±12.33φ*

±7.32#

±27.91#**

±0.46#**

±49.87#

(n=8)

(n=6)

BW : the body weight one day before injection of STZ or vehicle, BW : the body weight 14 days
1
2
after injection of STZ or vehicle. ECFV: extracellular fluid volume, GFR: glomerular filtration rate,
RW: renal weight; C: Nondiabetic control; DC: Diabetes+standard diet; DHS: Diabetes+high-salt
diet; DLS: Diabetes+low-salt diet. Values are means±SD. * p < 0.05 v pre-injection values, **p<
0.05 v DC, #p < 0.05 v C, φp<0.01 v C.

Materials and Methods
Male Wistar rats (obtained from the Medical and
Experimental Research Center, Adana), weighing
307±12.75 g (mean±SD), were used. The rats were
housed at constant room temperature (24°C) and on a
12:12 h light-dark cycle. The animals received standard
rat pellets (22% protein, 0.50% NaCl) and tap water
until they were given different diets. Initially, systolic
blood pressures (SBP) were measured by an indirect tailcuff method (Rat Tail BP Monitor, Harvard, Edenbridge,
Kent). For this purpose, the rats were warmed for 5
minutes at 34°C. Then, they were placed in a plastic
restrainer for SBP and HR measurements. Normotensive
rats (the rats with SBP values less than 130 mmHg) were
used. Streptozotocin (STZ) (Sigma Chemical, St. Louis,
MO) was dissolved in citrate buffer (0.1 M, pH 4.5) at a
concentration of 65 mg/mL, immediately prior to
injection. Either STZ (65 mg/kg; diabetic groups, n=24)
or citrate buffer vehicle (nondiabetic control group, C,
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n=9) were injected into the animals via the left jugular
vein under light ether anesthesia. Nondiabetic control rats
received standard rat pellets and tap water during the
study. One week after STZ injection, diabetic rats were
randomly assigned to one of three groups: 1) those given
standard rat pellets and tap water (DC, n=7), 2) those
given a high-salt diet [1% NaCl as drinking water and
low-salt pellets (0.02% NaCl)], (DHS, n=8), and 3) those
given a low-salt diet (distilled drinking water and low-salt
pellets), (DLS, n=9). Salt loading and salt restriction were
started 7 days after STZ injection and continued for oneweek. Two days after the injection of either STZ or
vehicle, urine samples were tested with multistix
(Diagnostix, Bayer, Germany) to detect glucosuria, an
indicator of diabetes.
Blood pressure, GFR and ECFV measurements were
performed under pentobarbital sodium (75 mg/kg, i.p.)
anesthesia 14 days after injections of STZ. Body
temperature was maintained by a heating lamp. After
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GROUP

SBP

DBP

MAP

HR

(mmHg)

(mmHg)

(mmHg)

(beats/min)

C

132.44

85.00

100.82

349.78

(n=9)

±6.42

±6.12

±5.52

±37.74

DC

102.50

68.33

78.39

295.67

(n=6)

±26.03*

±13.29*

±18.64*

±66.96

DHS

103.13

58.13

73.12

302.63

(n=8)

±17.92*

±7.04*#

±9.69*

±45.63

DLS

107.50

73.13

84.58

299.50

(n=8)

±15.81*

±11.00*

±11.54*

±39.85

Table 2.

Blood pressures and heart
rates in experimental groups.

SBP: Systolic, DBP: Diastolic, MAP: Mean, blood pressures. HR: Heart rate. C: Nondiabetic
control; DC: Diabetes+standard diet; DHS: Diabetes+high-salt diet; DLS: Diabetes+low-salt diet.
Values are means±SD. *p < 0.05 v C, #p < 0.05 v DLS.

tracheostomy, the animals were allowed to breathe
independently. The left femoral artery was cannulated
with PE-50 tubing (Clay-Adams, Parsipanny, NJ) which
was connected to a pressure transducer and a recorder
(Bioscience, Washington) for continuous recording of
arterial blood pressure and heart rate. Mean arterial
blood pressure (MAP) was accepted as the sum of 1/3
pulse pressure with diastolic pressure. Tubings (PE-50)
were inserted into the left femoral and jugular veins for
the infusions of drugs and isotonic NaCl, respectively. The
fluids in the cannulas were heparinized (50 IU/mL). The
urinary bladder was catheterized (PE-90) for urine
collection. After the jugular vein connection, 0.9% NaCl
was continuously infused (Infusion Pump, Model 210,
Cole-Parmer, USA) into the animal throughout the
experiment at a rate of 0.02 mL/min for the
compensation of insensible fluid losses.
Sodium thiocyanate (NaSCN) and inulin were used for
the determination of ECFV (19) and GFR (20),
respectively, by spectrophotometry. For these purposes a
control blood specimen (0.3 mL) was withdrawn at the
end of the stabilization period (30 minutes). After 5%
inulin (1.2 mL/kg) and 0.5 mL 1% NaSCN solutions in
isotonic saline were infused as i.v. bolus into the animals,
3.33% inulin solution in 0.9% NaCl was continuously
infused (0.01 mL/min) for one hour. Three blood samples
(0.2 mL) were withdrawn 0, 16 and 48 minutes after the

end of the last period for determination of plasma
NaSCN (only in the first sample) and inulin concentrations
(in each of the samples). Whenever blood was withdrawn,
it was centrifuged at 4°C and the volume deficit was
compensated with erytrocytes that were suspended in
0.9% NaCl. Urine was collected during two successive 32
minute periods to determine the amount of excreted
inulin. At the end of urine collection, 3 mL arterial blood
was withdrawn for the determination of glucose. The
kidneys were removed and weighed after separation from
their capsules. The plasma obtained was stored at -80°C
until assayed. Inulin clearance for each period was
calculated and the mean of the two periods was accepted
as GFR. Plasma glucose level was determined with by the
glucose oxidase method (Sclavo, Siena, Italy).
Statistics: Results are expressed as means ± SD. The
differences between groups were evaluated with KruskalWallis ANOVA and the Mann Whitney U test. The Wilcoxon
matched pairs test was used to evaluate the changes at
different times in the same group. Linear regression
analysis was applied between parameters. Differences
were considered statistically significant at p<0.05.
Results
STZ injected rats exhibited the characteristic
symptoms of diabetes. Body weights that were measured
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before and after STZ or vehicle injections, plasma
glucose, ECFV, GFR and renal weight values are shown in
Table 1. The nondiabetic group gained weight, whereas
the diabetic groups lost weight. Body weight was greater
in the control group than in each diabetic group (p<0.01)
and not significantly different between the diabetic
groups. All STZ-treated rats had glucosuria (> 110
mg/mL urine). Plasma glucose level was greater in each
diabetic group than the nondiabetic control group
(p<0.001) and not significantly different between the
diabetic groups. No significant differences were found
between C and DC with regard to ECFV and GFR. In DHS
and DLS, ECFV was greater than C and DC (p<0.05).
GFR was greater in the DLS group than in the C and DC
groups (p<0.05). Kidney weight increased in the diabetic
groups compared with C (p<0.05) but neither low- nor
high-salt diets significantly affected kidney weight in the
diabetic groups when they were compared with DC.
SBP, DBP and MAP were smaller in each diabetic
group than C (p<0.05) but no significant difference was
present between DC and the other the diabetic groups
(Table 2). When diabetic groups were put in order of salt
content in their diets, DBP and MAP tended to decrease
as the salt content in the diet increased (e.g. with regard
to DBP or MAP level, the order was DLS>DC>DHS).
There was a significant difference between DLS and DHS
with regard to DBP (p<0.05). HR tended to decrease in
each diabetic group compared with the nondiabetic
control group but the differences were nonsignificant. HR
showed no significant difference between the diabetic
groups.
Only in DC, there was an inverse correlation between
glucose and both DBP and MAP (r=-0.85, p<0.05).
There was a positive correlation between ECFV and HR
values in C (r=0.72, p<0.05), but a strong negative
correlation in DHS (r=-0.95, p<0.01).
Discussion
Over a period of 2 weeks, the weight of diabetic rats
decreased while the weight of the nondiabetic control
group tended to increase. This was an expected result
because of metabolic changes in diabetes. There was no
significant differences between the glucose levels of
diabetic groups. For this reason, we can accept that the
effects of low- and high-salt diets on ECFV, GFR and BP
levels in diabetics are not dependent on plasma glucose
levels.
Diabetes did not lead to a significant increase in ECFV,
but it has been reported that diabetes increases ECFV in
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another study (21). The cause of the difference may be
due to the short duration of diabetes in the present
study. However, it is an interesting condition in which
both high-and low-salt diets caused the increases in ECFV
of diabetic rats. In other words, although diabetes did not
affect ECFV significantly, it caused the rats to be unable
to maintain their ECFV in the normal range under both
low and high dietary-salt conditions. Consequently, we
can expect that body fluid volume control mechanisms fail
to balance the ECFV level in diabetic rats under stress
conditions.
Generally, severe diabetes decreases GFR (22), but
nonsevere diabetes increases it (5, 6). Thus, GFR may be
normal, low or high, depending on the severity of
diabetes. In our study, the unchanged GFR in the diabetic
control group can be understood if we consider this wide
variation in GFR values of diabetics. Although we did not
determine a significant increase in GFR and ECFV in the
diabetic control group, an increase or a tendency to
increase in GFR together with an increase in ECFV was
recorded at both salt restriction and loading stages. This
result confirms the conclusion that ECFV is an important
parameter that affects GFR in diabetes (23). An increase
in GFR parallel to that in ECFV is an acceptable
association because volume expansion is an important
stimulator of ANP secretion (24) and ANP plays an
important role in the development of hyperfiltration in
diabetes (25). However, in diabetics with salt loading,
ECFV significantly increased, but GFR did not. Therefore,
it can be accepted that all changes in GFR are not only due
to volume expansion. In other words, we can conclude
that salt restriction increases GFR also by mechanisms
other than the increase in ECFV since salt restriction
caused a significant increase in GFR. This result is
consistent with those of authors who state that the
change in GFR could not be explained only by sodium and
volume status (26) and that a low-salt diet increases GFR
(27) in diabetes.
Diabetes caused growth of the kidneys. This result
follows that of previous studies in which renal
hypertrophy was determined (5, 7). The increased renal
weight is partly due to a decrease in body weight (BW)
gain because it changes the renal weight/BW ratio. Since
low- and high- salt diets did not affect the amount of this
hypertrophy, we can accept that the amount of salt intake
is not important in the formation of renal hypertrophy
for short-term diabetes. However, the determination of
the total protein concentration in kidneys can give us
better information about renal hypertrophy because salt
can cause changes in fluid-electrolyte turnover that may
lead to microscopic changes in renal tissue. It has been
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reported that both high-salt (27) and low-salt (28) diets
caused renal growth in diabetes. But in the first study, the
severity of diabetes was less and the duration of diabetes
longer than in our present study, and in the second, there
was insulin-treated diabetes.
We recorded a reduction in the blood pressure of the
diabetics. This result agrees with the conclusions of
studies which had used the direct technique for
measurement of blood pressure (29-31). Normotension
or hypotension with lower total peripheral resistance
(TPR) have been reported in diabetes, although it has
been generally determined that hyperglycemia did not
affect or increase cardiac output (29, 32). Hence, it
seems that diabetes causes hypotension principally by
decreasing TPR. Actually, the changes that decrease TPR
are more prominent in diabetes (10, 26, 31), although
some findings show an increase of vascular constrictor
response (e.g. in vitro increases at vasoconstrictor
response to norepinephrine) (33). Also, a decrease in the
response of renin-angiotensin-aldosterone system activity
to saline infusion in diabetes has been reported (34).
There was a strong inverse correlation between DBP and
glucose levels in the diabetic control group in our study
and TPR is the principal determining factor of DBP (35).
Hence, it could be considered that hyperglycemia may
change mean blood pressure by affecting DBP.
Significantly, neither high- nor low-salt diets affected
SBP and MAP in diabetics. In another two studies also, it
has been concluded that a high sodium diet did not affect
blood pressure in diabetic rats (17, 27). However, in our
study, when diabetic groups were arranged according to
the salt contents of their diets, it was determined that
DBP and MAP tended to decrease from the low-salt group
to the high-salt group. The difference between these two
diabetic groups was statistically significant with regard to
DBP. Consequently, in diabetics, it can be accepted that
salt loading tends to reduce DBP, but salt restriction tends
to increase it. In addition, this result partly confirms the
suggestion that different salt amounts in diets may lead
to different BP measurements in studies on diabetes (9).
Although ECFV was increased by both low- and high-salt
diets in diabetics, DBP tended to increase in a low-salt diet
but to decrease in a high-salt diet. Therefore, it is likely
that different salt diets affect blood pressure via
mechanisms other than those just affecting ECFV. In both
low- and high salt diet conditions, the increase in ECFV
may lead to an increase in ANP and a decrease in plasma
renin activity (24). Thus, the sympathetic nervous system
activity which is a determinative factor of TPR, was
possibly affected by both low-salt and high-salt diets
because of reasons other than just increases in ECFV.

Actually, there is an attenuated suppression in reflex
response to stimulation of sympathetic nervous system
after dietary salt restriction in diabetic patients (36).
HR tended to decrease in the diabetic control group
but the difference was not significant. Many authors have
reported that diabetes decreased HR (30-32, 37), while
some researchers did not find diabetic bradycardia (15).
Consequently, we can state that the pathophysiologic
conditions in diabetes may decrease HR but the amount
of the decrease may vary possibly due to different
durations and severity of diabetes. The duration and
severity may affect the desensitization (38) and the
reduction (39, 40) of β-adrenergic receptors, plus
baroreflex mechanisms that control the heart rate (15),
in diabetes. In addition, the alterations in plasma level of
AVP partly depend on volume status that may change
during the course of diabetes (9) and AVP may affect HR
(16). We can state that the salt quantity of diet does not
play an important role in alterations of HR in short-term
diabetes because both low- and high-salt diets did not
cause a significant effect on HR. However, there was a
strong inverse correlation between ECFV and HR in the
high-salt diabetic group and a positive correlation in the
nondiabetic control group. On the other hand, there was
no correlation between the two parameters in both the
diabetic control and low-salt diabetic groups. Thus, the
function of feedback mechanisms that operate between
ECFV and HR could be modified by both diabetes and
dietary salt.
In summary, changes in the level of salt in the diet
may cause alterations in ECFV and GFR in diabetes.
However, the effects of salt restriction and loading on
these parameters may be in the same direction. In
addition, it is concluded that the DBP levels in diabetes
could be decreased with a high-salt diet and, both
diabetes and dietary salt can modify feedback
mechanisms that operate between ECFV and HR. More
detailed experiments that include the effects of dietary
salt on hormonal balances may contribute greatly in
clarifying the effects of salt on ECFV and DBP in
diabetes.
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